PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) | MicrobiomeTrials← Back to trialsNCT07169630
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2029-04-11
Enrollment target: 90 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Alzheimer Disease
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation…
Chandler, United StatesEst. completion Nov 3, 2028
Cognitive Impairment, MildCognitive DysfunctionAmyloid PlaqueNeurodegenerationInflammation, Brain
Accumulating evidence indicates that inflammation is prominent both in the blood and central nervous system (CNS) of Alz…
Phoenix, United StatesCompleted May 31, 2025
Aging
Background:
Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other…
Baltimore, United StatesEst. completion Dec 12, 2029